All articles by Eloise Mclennan

1. Pharma Technology Focus: treating zebras

   Pharma Technology Focus is now available on all devices. Read it for free here Horizon 2020, the European Union’s research and…
   Read More…

   24 Jan
2. Pharma Technology Focus: access to PrEP

   Pharma Technology Focus is now available on all devices. Read it for free here Breast cancer is the second most common…
   Read More…

   18 Dec
3. Pharma Technology Focus: improving public relations

   Pharma Technology Focus is now available on all devices. Read it for free here Every year, at-risk patients are encouraged to…
   Read More…

   20 Nov
4. Pharma Technology Focus: the dengue dilemma

   Pharma Technology Focus is now available on all devices. Read it for free here In August, Novartis became the poster child…
   Read More…

   29 Oct
5. Pharma Technology Focus: buyers clubs in the UK

   Pharma Technology Focus is now available on all devices. Read it for free here. Regulators are warming to the opportunities…
   Read More…

   22 Aug
6. Pharma Technology Focus: Taming big pharma

   Pharma Technology Focus is now available on all devices. Read it for free here Drug resistant tuberculosis causes one third of…
   Read More…

   29 Jul
7. Pharma Technology Focus: the deep dive for new drugs

   Pharma Technology Focus is now available on all devices. Read it for free here Earlier this year, former banker and superbug…
   Read More…

   20 Jun
8. Pharma Technology Focus: digitising the API supply chain

   Pharma Technology Focus is now available on all devices. Read it for free here In March, US Food and Drug Administration…
   Read More…

   24 May
9. Pharma Technology Focus: is a memory loss drug on the horizon?

   Pharma Technology Focus is now available on all devices. Read it for free here In February, Johnson & Johnson’s depression drug…
   Read More…

   25 Apr
10. Pharma Technology Focus: the absence of antivenom in pharma

    Pharma Technology Focus is now available on all devices. Read it for free here Following the news that the UK BioIndustry…
    Read More…

    21 Mar